C4 Therapeutics Insider Trades

CCCC

Track insider trading activity from C4 Therapeutics executives and directors. See which insiders are buying and selling CCCC stock.

Trades Last 12 Months

CCCC Price

All Insider Trades for C4 Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $243k 75,612 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 3,662 shares
$3.14
$3.21
Grogan Donna Roy Director
Holding Value $255k 79,471 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.5k 4,618 shares
$3.14
$3.21
Adams Kendra Chief Financial Officer
Holding Value $1.23M 382,323 shares
Last Trade
Sep 18, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.41k 2,775 shares
$3.39
$3.21
Reyno Leonard Chief Medical Officer
Holding Value $1.22M 379,803 shares
Last Trade
Jul 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.2k 15,325 shares
$4.06
$3.21
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Fawell Stephen Director
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Bessen Laura Director
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Koppikar Utpal Director
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Hughes Owen Director
Holding Value $199k 62,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 62,000 shares
$4.25
$3.21
Grogan Donna Roy Director
Holding Value $230k 71,512 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.5k 5,370 shares
$2.70
$3.21
Hirsch Andrew President & CEO
Holding Value $3.48M 1,083,991 shares
Last Trade
Feb 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$38.6k 20,400 shares
$1.89
$3.21
Mahaney Paige Chief Scientific Officer
Holding Value $1.08M 336,910 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.62k 2,446 shares
$1.89
$3.21
Schick Kelly Chief People Officer
Holding Value $986k 307,150 shares
Last Trade
Feb 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.6k 20,950 shares
$1.89
$3.21
Boyle Scott N Chief Business Officer
Holding Value $959k 298,801 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.7k 7,269 shares
$1.89
$3.21
Reyno Leonard Chief Medical Officer
Holding Value $1.22M 379,803 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31.3k 16,579 shares
$1.89
$3.21
Mossler Mark Chief Accounting Officer
Holding Value $241k 75,184 shares
Last Trade
Feb 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.8k 9,420 shares
$1.89
$3.21
Siegel Jolie Chief Legal Officer
Holding Value $346k 107,939 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.27k 2,914 shares
$3.18
$3.21
Fisher Stewart Chief Scientific Officer
Holding Value $422k 131,371 shares
Last Trade
Sep 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.3k 2,250 shares
$6.36
$3.21
Salter Malcolm Director
Holding Value $104k 32,500 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 32,500 shares
$4.05
$3.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up